삼성서울병원

Ko En

내분비대사내과 김태혁 교수

진료분야
갑상선 질환, 갑상선암
진료일정 11 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 12 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2016.02 서울대학교 의과대학 대학원 의학과 졸업(박사)
2010.02 서울대학교 의과대학 대학원 의학과 졸업(석사)
2005.02 서울대학교 의과대학 의학과 졸업(의학사)

경력

경력
2019.03 ~현재 성균관의대 삼성서울병원 내과 조교수
2018.03 ~ 2019.02 삼성서울병원 내분비-대사 내과 전임대우조교수
2015.03 ~ 2018.02 삼성서울병원 내분비-대사 내과 임상전임강사
2015.10 내분비-대사 내과 분과전문의 자격 취득
2014.03 ~ 2015.02 서울대학교병원 내분비-대사 내과 진료조교수
2013.05 ~ 2014.02 서울대학교병원 내분비-대사 내과 전임의
2011.05 ~ 2013.04 국군대전병원 내과 군의관
2010.05 ~ 2011.04 22사단신교대대 의무실장
2010.03 내과 전문의 자격 취득
2006.03 ~ 2010.02 서울대학교병원 내과 레지던트
2005.03 ~ 2006.02 서울대학교병원 인턴 수료

학회활동

학회활동
2014.11 ~ 현재 미국암연구학회(AACR) Associate member
2014.02 ~ 현재 아세아-오세아니아 갑상선 연맹(AOTA) member
2014.02 ~ 현재 대한갑상선학회 평생회원
2013.08 ~ 현재 대한당뇨병학회 정회원
2013.03 ~ 현재 미국갑상선학회(ATA) Associate member
2013.03 ~ 현재 미국내분비학회 Associate member
2013.03 ~ 현재 대한내분비학회 평생회원
2010.03 ~ 현재 대한내과학회 정회원
2015.09 ~ 2017.08 대한갑상선학회 부총무
  • NUCL MED COMMUN 2020 10.1097/MNM.0000000000001138 The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study Park1, H; Kim, HI; Park, J; Park, SY; Kim, TH; Chung, JH; Choi, JY; Kim, SW
    View PubMed
  • CANCERS 2020 10.3390/cancers12030625 Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer Kim1, H; Park, SY; Choe, JH; Kim, JS; Hahn, SY; Kim, SW; Chung, JH; Jung, J; Kim, TH
    View PubMed
  • CLIN ENDOCRINOL 2020 10.1111/cen.14167 Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma? Park1, KW; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • ACTA RADIOL 2020 10.1177/0284185119847677 Comparison of ultrasonography and CT for preoperative nodal assessment of patients with papillary thyroid cancer: diagnostic performance according to primary tumor size Yang1, SY; Shin, JH; Hahn, SY; Lim, Y; Hwang, SY; Kim, TH; Kim, JS
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-55370-w Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer Kim1, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • THYROID 2019 10.1089/thy.2019.0261 Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis Park1, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH
    View PubMed
  • EUR J NUTR 2019 10.1007/s00394-018-1837-4 Non-immune-related hypothyroidism and its relationship with excess iodine Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • THYROID 2019 10.1089/thy.2019.0246 Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study Oh1, HS; Shin, DY; Kim, M; Park, SY; Kim, TH; Kim, BH; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Lim, DJ; Kim, WG
    View PubMed
  • THYROID 2019 10.1089/thy.2018.0541 Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma Kim1, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL
    View PubMed
  • ENDOCRINE 2019 10.1007/s12020-018-1807-x Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin Cho1, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW
    View PubMed
  • EUR J NUTR 2019 10.1007/s00394-017-1587-8 Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015 Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • ORAL ONCOL 2019 10.1016/j.oraloncology.2018.12.014 Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma Kim1, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2018.0263 Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea Oh1, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH
    View PubMed
  • J CLIN ENDOCR METAB 2018 10.1210/jc.2018-01386 Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma Park1, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.10.029 Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study Kim1, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.09.008 Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study Kim1, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-31955-9 Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance Lee1, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002 Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • BRIT J SURG 2018 10.1002/bjs.10830 Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma Park1, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0550 Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea Cho1, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2018 10.3904/kjirn.2016.051 Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area Kim1, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0356 Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0356 Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
    View PubMed
  • HISTOPATHOLOGY 2018 10.1111/his.13401 Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma Kim1, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.01.021 Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis Kim1, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • ANN INTERN MED 2018 10.7326/M17-1398 Antithyroid Drugs and Congenital Malformations A Nationwide Korean Cohort Study Seo1, GH; Kim, TH; Chung, JH
    View PubMed
  • J CLIN ENDOCR METAB 2018 10.1210/jc.2017-01775 High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance Kim1, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0190738 Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015) Park1, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW
    View PubMed
  • CLIN ENDOCRINOL 2018 10.1111/cen.13489 Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up Sohn1, SY; Kim, HI; Kim, YN; Kim, TH; Kim, W; Chung, JH
    View PubMed
  • BRIT J SURG 2018 10.1002/bjs.10655 Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH
    View PubMed
  • Oncoimmunology 2018 10.1080/2162402X.2017.1375642 Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer Kim1, HI; Kim, M; Lee, SH; Park, SY; Kim, YN; Kim, H; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Kim, SW; Lee, DH; Park, K; Ahn, MJ; Chung, JH; Shong, YK; Kim, WG; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0214 Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer Jeon1, MJ; Kim, YN; Sung, TY; Hong, SJ; Cho, YY; Kim, TY; Shong, YK; Kim, WB; Kim, SW; Chung, JH; Kim, TH; Kim, WG
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22430 Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations Hahn1, SY; Kim, TH; Ki, CS; Kim, SW; Ahn, S; Shin, JH; Chung, JH
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-17176-6 Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer Kim1, H; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1381-7 Validation of dynamic risk stratification in pediatric differentiated thyroid cancer Sohn1, SY; Kim, YN; Kim, HI; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • Cancer Med 2017 10.1002/cam4.1160 Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Jang, HW; Kim, YN; Kim, H; Ahn, HS; Kim, K; Kim, SW; Chung, JH
    View PubMed
  • THYROID 2017 10.1089/thy.2016.0677 Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma Hahn1, SY; Shin, JH; Oh, YL; Kim, TH; Lim, Y; Choi, JS
    View PubMed
  • CLIN ENDOCRINOL 2017 10.1111/cen.13344 Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer Kim1, HI; Kim, TH; Kim, H; Kim, YN; Jang, HW; Kim, JH; Hur, KY; Chung, JH; Kim, SW
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1363-9 Hormetic effect of triiodothyronine in metabolically healthy obese persons Jun1, JE; Kim, TH; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Kim, JH; Kim, SW; Chung, JH; Min, YK; Lee, MK
    View PubMed
  • ORAL ONCOL 2017 10.1016/j.oraloncology.2017.06.004 Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma Kim1, TH; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Jeong, JG; Kim, SW; Chung, JH
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1340-3 Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer Kim1, TH; Ki, CS; Hahn, SY; Oh, YL; Jang, HW; Kim, SW; Chung, JH; Shin, JH
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0182090 Subclinical thyroid dysfunction and risk of carotid atherosclerosis Kim1, H; Kim, TH; Kim, HI; Park, SY; Kim, YN; Kim, S; Kim, MJ; Jin, SM; Hur, KY; Kim, JH; Lee, MK; Min, YK; Chung, JH; Kang, M; Kim, SW
    View PubMed
  • THYROID 2017 10.1089/thy.2016.0648 Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma Kim1, H; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Chi, SA; Jung, SH; Kim, YN; Kim, HI; Kim, SW; Chung, JH
    View PubMed
  • Osteoporos Int. 2017 Apr;28(4):1377-1384. doi: 10.1007/s00198-016-3892-0. Epub 2017 Feb 10. Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis Lee DY11,2, Jee JH3, Cho YY1, Jang JY1, Yu TY1, Kim TH1, Hong YJ1, Hong WJ1, Jin SM1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK4.
    View PubMed
  • Clin Endocrinol (Oxf). 2017 Mar;86(3):438-443. doi: 10.1111/cen.13254. Epub 2016 Nov 2. Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years? Kim M11, Kim YN2, Kim WG1, Park S1, Kwon H1, Jeon MJ1, Ahn HS3, Jung SH4, Kim SW2, Kim WB1, Chung JH2, Shong YK1, Kim TH2, Kim TY1.
    View PubMed
  • Endocr Relat Cancer. 2017 Feb;24(2):97-106. doi: 10.1530/ERC-16-0421. Comprehensive screening for PD-L1 expression in thyroid cancer Ahn S11, Kim TH2, Kim SW2, Ki CS3, Jang HW4, Kim JS5, Kim JH5, Choe JH5, Shin JH6, Hahn SY6, Oh YL7, Chung JH8.
    View PubMed
  • Head Neck. 2017 Feb;39(2):269-274. doi: 10.1002/hed.24578. Epub 2016 Sep 12. Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area Lee YB11, Cho YY2, Jang JY3, Kim TH1, Jang HW4, Chung JH1, Oh YL5, Kim SW1.
    View PubMed
  • Endocrine. 2017 Feb;55(2):503-512. doi: 10.1007/s12020-016-1138-8. Epub 2016 Oct 5. The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects Lee DY11,2, Jee JH3, Jun JE1, Kim TH1, Jin SM1, Hur KY1, Kim SW1, Chung JH1, Lee MK1, Kim JH4,5.
    View PubMed
  • Ann Lab Med. 2017 Jan;37(1):63-65. doi: 10.3343/alm.2017.37.1.63. First Report of Familial Dysalbuminemic Hyperthyroxinemia With an ALB Variant Cho YY11,2, Song JS3, Park HD3, Kim YN1, Kim HI1, Kim TH1, Chung JH1, Ki CS4, Kim SW5.
    View PubMed
  • Thyroid. 2017 Jan;27(1):29-38. doi: 10.1089/thy.2016.0171. Epub 2016 Dec 9. Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study Jun JE11, Jee JH2, Bae JC3, Jin SM1, Hur KY1, Lee MK1, Kim TH1, Kim SW1, Kim JH1.
    View PubMed
  • PLoS One. 2017 Jan 12;12(1):e0169775. doi: 10.1371/journal.pone.0169775. eCollection 2017. Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication Kim HI11, Kim TH1, Kim H1, Kim YN1, Jang HW2, Chung JH1, Moon SM3, Jhun BW3, Lee H3, Koh WJ3, Kim SW1.
    View PubMed
  • Endocr Relat Cancer. 2016 Oct;23(10):813-23. doi: 10.1530/ERC-16-0219. Epub 2016 Aug 15. TERT promoter mutations and long-term survival in patients with thyroid cancer Kim TH11, Kim YE2, Ahn S3, Kim JY4, Ki CS5, Oh YL3, Kim K6, Yun JW7, Park WY7, Choe JH8, Kim JH8, Kim JS8, Kim SW1, Chung JH9.
    View PubMed
  • Head Neck. 2016 Oct;38(10):1501-8. doi: 10.1002/hed.24469. Epub 2016 Apr 7. Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence Cho YY11, Jang HW2, Jang JY1, Kim TH1, Choe JH3, Kim JH3, Kim JS3, Kim SW1, Chung JH4.
    View PubMed
  • Histopathology. 2016 Jul;69(1):45-53. doi: 10.1111/his.12902. Epub 2016 Jan 11. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications Joung JY11, Kim TH1, Jeong DJ1, Park SM1, Cho YY1, Jang HW2, Jung YY3, Oh YL3, Yim HS4, Kim YL4, Chung JH1, Ki CS5, Kim SW1.
    View PubMed
  • Cancer Med. 2016 May;5(5):769-77. doi: 10.1002/cam4.636. Epub 2016 Jan 18. Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques Kim TH11, Jeong DJ1, Hahn SY2, Shin JH2, Oh YL3, Ki CS4, Kim JW4, Jang JY1, Cho YY1, Chung JH1, Kim SW1.
    View PubMed
  • Nutr Res Pract. 2016 Apr;10(2):167-74. doi: 10.4162/nrp.2016.10.2.167. Epub 2015 Dec 11. Dietary evaluation of a low-iodine diet in Korean thyroid cancer patients preparing for radioactive iodine therapy in an iodine-rich region Ju DL11, Park YJ2, Paik HY3, Kim MJ4, Park S5, Jung KY6, Kim TH7, Choi HS8, Song YJ4.
    View PubMed
  • PLoS One. 2015 Dec 17;10(12):e0145292. doi: 10.1371/journal.pone.0145292. eCollection 2015. A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels Kim TH11, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.
    View PubMed
  • Diabet Med. 2015 Feb;32(2):274-9. doi: 10.1111/dme.12607. Epub 2014 Oct 29. Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring Jin SM11, Kim TH, Oh S, Baek J, Joung JY, Park SM, Cho YY, Sohn SY, Hur KY, Lee MS, Lee MK, Kim JH.
    View PubMed

해당하는 결과가 없습니다.